Juno Bio is a biotechnology company that uses machine learning and bioinformatics to analyse and predict how best to manipulate microbiomes.
Juno Bio has raised $3.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Juno Bio's investors include Entrepreneurs First, Acequia Capital (AceCap), Ada Ventures, Artesian VC, AI Seed.
Juno Bio is headquartered in London, United Kingdom.
Juno Bio is a biotechnology company that uses machine learning and bioinformatics to analyse and predict how best to manipulate microbiomes.
Juno Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Juno Bio — Funding & Investors." VCBacked, July 16, 2026, https://www.vcbacked.co/company/juno-bio. Accessed August 13, 2026.
VCBacked. (2026). Juno Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/juno-bio
{{cite web |title=Juno Bio — Funding & Investors |url=https://www.vcbacked.co/company/juno-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated